Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]
Main Authors: | , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2020-12-01
|
Series: | Biochemistry and Biophysics Reports |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2405580820301060 |
id |
doaj-2a65e57fdf3a42a3a16790812ebf494e |
---|---|
record_format |
Article |
spelling |
doaj-2a65e57fdf3a42a3a16790812ebf494e2020-12-21T04:46:12ZengElsevierBiochemistry and Biophysics Reports2405-58082020-12-0124100797Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726]Takahito Hara0Akiko Kimura1Tohru Miyazaki2Hiroshi Tanaka3Megumi Morimoto4Katsuhiko Nakai5Junpei Soeda6Innovation Promotion, Shonan Research Central Office, Research, Takeda Pharmaceutical Company Limited, 2-26-1 Muraoka-Higashi, Fujisawa-shi, Kanagawa, 251-8555, Japan; Corresponding author.Oncology Therapeutic Area Unit for Japan & Asia, Takeda Pharmaceutical Company Limited, 4-1-1 Dosho-machi Chuo-ku Osaka-shi, Osaka, 540-8645, JapanDepartment of Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8668, JapanAxcelead Drug Discovery Partners, Inc., 2-26-1Muraoka-Higashi, Fujisawa-shi, Kanagawa, 251-0012, JapanInnovation Promotion, Shonan Research Central Office, Research, Takeda Pharmaceutical Company Limited, 2-26-1 Muraoka-Higashi, Fujisawa-shi, Kanagawa, 251-8555, JapanOncology Therapeutic Area Unit for Japan & Asia, Takeda Pharmaceutical Company Limited, 4-1-1 Dosho-machi Chuo-ku Osaka-shi, Osaka, 540-8645, JapanDepartment of Japan Medical Affairs, Japan Oncology Business Unit, Takeda Pharmaceutical Company Limited, 2-1-1 Nihonbashi-Honcho, Chuo-ku, Tokyo, 103-8668, Japan; Corresponding author.http://www.sciencedirect.com/science/article/pii/S2405580820301060 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Takahito Hara Akiko Kimura Tohru Miyazaki Hiroshi Tanaka Megumi Morimoto Katsuhiko Nakai Junpei Soeda |
spellingShingle |
Takahito Hara Akiko Kimura Tohru Miyazaki Hiroshi Tanaka Megumi Morimoto Katsuhiko Nakai Junpei Soeda Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] Biochemistry and Biophysics Reports |
author_facet |
Takahito Hara Akiko Kimura Tohru Miyazaki Hiroshi Tanaka Megumi Morimoto Katsuhiko Nakai Junpei Soeda |
author_sort |
Takahito Hara |
title |
Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] |
title_short |
Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] |
title_full |
Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] |
title_fullStr |
Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] |
title_full_unstemmed |
Corrigendum to “Cabozantinib inhibits AXL- and MET-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [Biochem. Biophys. Rep. 21 (2020) 100726] |
title_sort |
corrigendum to “cabozantinib inhibits axl- and met-dependent cancer cell migration induced by growth-arrest-specific 6 and hepatocyte growth factor” [biochem. biophys. rep. 21 (2020) 100726] |
publisher |
Elsevier |
series |
Biochemistry and Biophysics Reports |
issn |
2405-5808 |
publishDate |
2020-12-01 |
url |
http://www.sciencedirect.com/science/article/pii/S2405580820301060 |
work_keys_str_mv |
AT takahitohara corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 AT akikokimura corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 AT tohrumiyazaki corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 AT hiroshitanaka corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 AT megumimorimoto corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 AT katsuhikonakai corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 AT junpeisoeda corrigendumtocabozantinibinhibitsaxlandmetdependentcancercellmigrationinducedbygrowtharrestspecific6andhepatocytegrowthfactorbiochembiophysrep212020100726 |
_version_ |
1724375670611509248 |